CHARLOTTE-Wyeth-Lederle Vaccines of Philadelphia continues to expand its 215-acre manufacturing, research and development campus in Sanford, NC with a new $250 million, 115,000-sf production facility, 80 miles east of Downtown Charlotte.
The campus produces pediatric vaccines that immunize humans against bacterial infections, according to Industrial Information Resources Inc., a Houston-based industry researcher.
The new expansion follows Wyeth-Lederle's completion of a $48 million, 46,000-sf bulk manufacturing structure that produces two new company vaccines, Prevenar and Meningitac. ADP Marshall Inc. of Rumford, RI, a Fluor Daniel company, was the general contractor.
Recommended For You
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
